There’s still a lot we don’t know about how Parkinson’s disease develops. But one lifestyle intervention already has strong evidence behind it.

Two recent chemistry studies pinpoint reactions that may link the gut microbiome to the development of Parkinson's disease.

Researchers are using functionalized nanodiamonds to precisely monitor neuronal activity at the cellular level, enhancing ...

The findings shed light on the molecular mechanism behind the drug levodopa (L-Dopa), widely used to treat Parkinson's disease. A hallmark of the condition is progressively diminishing dopamine ...

His areas of research interest include the psychiatric and cognitive complications of Parkinson's disease ... history of an ICD before PD onset, and dopamine agonist therapy-have been found ...

Caffeine Affects Brain Dopamine Function in Patients With Parkinson's Disease May 28, 2024 — Regular high caffeine consumption affects dopamine function in patients with Parkinson's disease ...

while reward-oriented behaviors depend on rapid dopamine action. This distinction helps clarify how L-Dopa alleviates motor symptoms in Parkinson's disease but may not improve cognitive function.

Parkinson’s patients lack sufficient amounts of a neurotransmitter called dopamine. Standard treatment includes the drug levodopa, a compound that a brain enzyme converts into dopamine.

Treatments targeting alpha-synuclein aggregation account for 26% of the 7MM' pipeline disease-modifying therapies for ...

Sep. 24, 2024 — Parkinson's disease ... and neurological disorders attributed to dysfunctions in specific dopamine ... Alzheimer's Drug May Slow Down Cognitive Decline in Dementia With Lewy ...